Видео ютуба по тегу Speaker: Ruben Mesa

ASH Meeting on Hematologic Malignancies: Ruben Mesa, MD
ASH Meeting on Hematologic Malignancies: Ruben Mesa, MD
Gol de penalti en el colombino, marcado por Rubén Mesa.
Gol de penalti en el colombino, marcado por Rubén Mesa.
MedNews Week Keynote Lecture: Ruben Mesa (UT Health San Antonio)
MedNews Week Keynote Lecture: Ruben Mesa (UT Health San Antonio)
Dr. Ruben Mesa on the importance of diversity in clinical trials
Dr. Ruben Mesa on the importance of diversity in clinical trials
Ruben Mesa, MD, Co-Chair, 2017 ASH Meeting on Hematologic Malignancies
Ruben Mesa, MD, Co-Chair, 2017 ASH Meeting on Hematologic Malignancies
MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa
MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa
7th Annual Women & MPN Conference- Dr. Ruben Mesa
7th Annual Women & MPN Conference- Dr. Ruben Mesa
Complimentary Therapeutic Strategies- Dr. Ruben Mesa, UT San Antonio, USA
Complimentary Therapeutic Strategies- Dr. Ruben Mesa, UT San Antonio, USA
MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa
MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa
MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa
MedNews Week Keynote - New Therapies for Myeloproliferative Neoplasms - Dr. Ruben Mesa
Advances in the science and treatment of MPNs
Advances in the science and treatment of MPNs
3 Landmark study Dr Ruben Mesa
3 Landmark study Dr Ruben Mesa
Unmet needs in MPN treatment
Unmet needs in MPN treatment
SIMPLIFY studies: analysis of the meaningful symptomatic change in patients with myelofibrosis
SIMPLIFY studies: analysis of the meaningful symptomatic change in patients with myelofibrosis
Clinical outcomes for patients with myelofibrosis after transition from ruxolitinib to momelotinib
Clinical outcomes for patients with myelofibrosis after transition from ruxolitinib to momelotinib
2017 ASH MHM: Focus on MPN – Ruben Mesa, MD
2017 ASH MHM: Focus on MPN – Ruben Mesa, MD
What to look out for at ASH: focus on MPNs
What to look out for at ASH: focus on MPNs
The importance of targeting other pathways after JAKi treatment failure
The importance of targeting other pathways after JAKi treatment failure
Sonus faber Factories in Italy
Sonus faber Factories in Italy
WHO WINS THIS FIGHT?
WHO WINS THIS FIGHT?